Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonoxynol-9 for HIV prevention
NCT00000926Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Nonoxynol-9 with Placebo (2 arms). Primary endpoint: Incidence of HIV Infection. Status: completed.
02
Drugs
nonoxynol-9
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000926.